Immunogenetherapy of Glioma by Mlfn-Γ Transfected Neural Precursor Cells:An Experimental Study

ZHANG Xiao-zhi,XU Hai-wei,CHEN Wei,LI Xu
DOI: https://doi.org/10.3969/j.issn.1673-5269.2006.13.004
2006-01-01
Abstract:OBJECTIVE:To examine the feasibility of using genetically modified embryonic stem(ES) cell-derived neural precursor cell(NPC) in glioma gene therapy.METHODS:After being cultured in NPCs/pTracer/mIFN-γ conditioned medium,Cell proliferation of mouse malignant glioma cell line G422_((s)) was measured by MTT method and the apoptosis was observed by TUNEL in vitro.The mouse glioma model was established by using DAPI labeled G422 cell line.NPCs/pTracer/mIFN-γ was inoculated in intracranial glioma,then the distribution and migration of these cells in glioma-bearing brain were observed and the survival time and brain tumor volume were compared between inoculating(NPCs/p-)Tracer/mIFN-γ and the control.RESULTS: The was observed in the G422 cells incubated in the presence of NPCs/pTracer/mIFN-γ conditioned medium(χ~2=7.21,P=0.032).(NPCs/pTracer/m-)IFN-γ conditioned medium induced G422 cells to apoptosis in vitro,after being treated with 50% conditioned medium 24 h,48 h,72 h later.The apoptic cell number was(2.5±0.9)/medium field,((3.4±)1.2)/medium field and(6.6±2.0)/medium field,respectively,(t: 2.37,2.56,2.80 respectively,P value: 0.041,0.034,0.022 respectively).With DAPI labeled G422 cells and GFP expressing NPCs,it demonstrated that NPCs,after being implanted into experimental intracranial gliomas in vivo,distributed themselves migrated uniquely in juxtaposition to widely expanding and aggressively advancing tumor cells.Glioma-bearing mice with IFN-γ-secreting NPCs demonstrated prolonged survival(28.5±0.98) d,(P=0.012) and the tumors were significantly smaller(27.54±0.86) mm~3 in size compared with those in the control groups(62.09±0.55) mm~3(P=0.015).CONCLUSION: NPCs from genetically modified ES cells can be used as carriers for glioma gene therapy.
What problem does this paper attempt to address?